FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597759689> ?p ?o ?g. }

• W2597759689 endingPage "1766" @default.
• W2597759689 startingPage "1757" @default.
• W2597759689 abstract "Adenocarcinoma is the most common type of non-small-cell lung cancer (NSCLC). Adenocarcinoma with epidermal growth factor receptor (EGFR) mutations accounts for 8%-30% of all cases of NSCLC depending on the geography and ethnicity. EGFR-mutated NSCLC usually responds to first-line therapy with EGFR tyrosine kinase inhibitors (TKIs). However, there is eventual loss of efficacy to TKIs due to development of resistance. The most frequent cause for resistance is a second EGFR mutation in exon 20 (T790M), which is encountered in up to 62% of patients. Osimertinib is one of the third-generation EGFR TKIs with a high selective potency against T790M mutants. In Phase I trial of osimertinib in advanced lung cancer after progression on EGFR TKIs, the response rate and disease control rate were 61% and 95%, respectively. A subsequent Phase II (AURA2) trial demonstrated a disease control rate of 92%, a response rate of 71%, a median duration of response of 7.8 months, and a median progression-free survival of 8.6 months. Osimertinib was approved by the US Food & Drug Administration in November 2015 for patients whose tumors exhibited T790M mutation and for those with progressive disease on other EGFR TKIs. In this review, we address the role of EGFR TKIs in the management of EGFR mutation lung cancer and the mechanisms of resistance to TKIs with a focus on the role of osimertinib. Data from completed trials of osimertinib, ongoing trials, as well as novel diagnostic methods to detect EGFR T790M mutation are reviewed." @default.
• W2597759689 created "2017-04-07" @default.
• W2597759689 creator A5027087424 @default.
• W2597759689 creator A5030127760 @default.
• W2597759689 creator A5041570847 @default.
• W2597759689 creator A5046063152 @default.
• W2597759689 date "2017-03-01" @default.
• W2597759689 modified "2023-10-12" @default.
• W2597759689 title "Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)" @default.
• W2597759689 cites W1505421350 @default.
• W2597759689 cites W1546552389 @default.
• W2597759689 cites W1845440762 @default.
• W2597759689 cites W1908940658 @default.
• W2597759689 cites W1963826141 @default.
• W2597759689 cites W1979671400 @default.
• W2597759689 cites W1987283660 @default.
• W2597759689 cites W1988827171 @default.
• W2597759689 cites W2027735722 @default.
• W2597759689 cites W2029446677 @default.
• W2597759689 cites W2044433401 @default.
• W2597759689 cites W2050211354 @default.
• W2597759689 cites W2054133698 @default.
• W2597759689 cites W2076178766 @default.
• W2597759689 cites W2081732737 @default.
• W2597759689 cites W2088540000 @default.
• W2597759689 cites W2096198395 @default.
• W2597759689 cites W2099742478 @default.
• W2597759689 cites W2104962676 @default.
• W2597759689 cites W2111662961 @default.
• W2597759689 cites W2121641332 @default.
• W2597759689 cites W2126177831 @default.
• W2597759689 cites W2128385295 @default.
• W2597759689 cites W2129656399 @default.
• W2597759689 cites W2131964519 @default.
• W2597759689 cites W2136601558 @default.
• W2597759689 cites W2138089710 @default.
• W2597759689 cites W2142865455 @default.
• W2597759689 cites W2143859186 @default.
• W2597759689 cites W2145643405 @default.
• W2597759689 cites W2146418087 @default.
• W2597759689 cites W2150575159 @default.
• W2597759689 cites W2154149901 @default.
• W2597759689 cites W2159013299 @default.
• W2597759689 cites W2165803850 @default.
• W2597759689 cites W2171139285 @default.
• W2597759689 cites W2171237493 @default.
• W2597759689 cites W2207941545 @default.
• W2597759689 cites W2210071992 @default.
• W2597759689 cites W2256191967 @default.
• W2597759689 cites W2292957477 @default.
• W2597759689 cites W2337836619 @default.
• W2597759689 cites W2339922740 @default.
• W2597759689 cites W2342166807 @default.
• W2597759689 cites W2383661457 @default.
• W2597759689 cites W2439241851 @default.
• W2597759689 cites W2915478882 @default.
• W2597759689 doi "https://doi.org/10.2147/ott.s100650" @default.
• W2597759689 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5370386" @default.
• W2597759689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28367058" @default.
• W2597759689 hasPublicationYear "2017" @default.
• W2597759689 type Work @default.
• W2597759689 sameAs 2597759689 @default.
• W2597759689 citedByCount "16" @default.
• W2597759689 countsByYear W25977596892017 @default.
• W2597759689 countsByYear W25977596892018 @default.
• W2597759689 countsByYear W25977596892019 @default.
• W2597759689 countsByYear W25977596892020 @default.
• W2597759689 countsByYear W25977596892022 @default.
• W2597759689 crossrefType "journal-article" @default.
• W2597759689 hasAuthorship W2597759689A5027087424 @default.
• W2597759689 hasAuthorship W2597759689A5030127760 @default.
• W2597759689 hasAuthorship W2597759689A5041570847 @default.
• W2597759689 hasAuthorship W2597759689A5046063152 @default.
• W2597759689 hasBestOaLocation W25977596891 @default.
• W2597759689 hasConcept C121608353 @default.
• W2597759689 hasConcept C126322002 @default.
• W2597759689 hasConcept C143998085 @default.
• W2597759689 hasConcept C2776256026 @default.
• W2597759689 hasConcept C2777626846 @default.
• W2597759689 hasConcept C2777930144 @default.
• W2597759689 hasConcept C2778087573 @default.
• W2597759689 hasConcept C2779438470 @default.
• W2597759689 hasConcept C2780580887 @default.
• W2597759689 hasConcept C2780586478 @default.
• W2597759689 hasConcept C2781182431 @default.
• W2597759689 hasConcept C502942594 @default.
• W2597759689 hasConcept C71924100 @default.
• W2597759689 hasConceptScore W2597759689C121608353 @default.
• W2597759689 hasConceptScore W2597759689C126322002 @default.
• W2597759689 hasConceptScore W2597759689C143998085 @default.
• W2597759689 hasConceptScore W2597759689C2776256026 @default.
• W2597759689 hasConceptScore W2597759689C2777626846 @default.
• W2597759689 hasConceptScore W2597759689C2777930144 @default.
• W2597759689 hasConceptScore W2597759689C2778087573 @default.
• W2597759689 hasConceptScore W2597759689C2779438470 @default.
• W2597759689 hasConceptScore W2597759689C2780580887 @default.
• W2597759689 hasConceptScore W2597759689C2780586478 @default.
• W2597759689 hasConceptScore W2597759689C2781182431 @default.

• next